Arvind Remedies inks MoU with Adesh University to launch
new drug
17/06/2014 10:36
Arvind Remedies Ltd. said that it has inked a memorandum of understanding with Adesh University, Punjab, to transfer the paten right to the company in order to launch a new drug. “The MoU is to transfer the patent right for manufacturing and marketing of formulation products from botanical source for treatment of Type 2 diabetes, coronary hear disease, neuro and anti depression,” the company said in a filing to the Bombay Stock Exchange. The company said these drugs would be manufactured in the form of tablets and would be launched in the domestic market by 2017 followed by the global market.
17/06/2014 10:36
Arvind Remedies Ltd. said that it has inked a memorandum of understanding with Adesh University, Punjab, to transfer the paten right to the company in order to launch a new drug. “The MoU is to transfer the patent right for manufacturing and marketing of formulation products from botanical source for treatment of Type 2 diabetes, coronary hear disease, neuro and anti depression,” the company said in a filing to the Bombay Stock Exchange. The company said these drugs would be manufactured in the form of tablets and would be launched in the domestic market by 2017 followed by the global market.
